Based on previous reports, surviving dormant cancer cells may over-express insulin-like growth factor-1 receptor (IGF-1R) during recurrence [29] and Axl may mediate different signals in high and low glucose situations [2, 30]. The gene discussed is AXL; the disease is cancer.